Evaluation of Indian Gooseberry/ Amla in the Management of Chronic Periodontitis
Evaluation of Amla (Emblica Officinalis) as an Adjunct to Non-surgical Periodontal Therapy in Patients With Chronic Periodontitis -A Clinical and Biochemical Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aimed to evaluate the influence of amla (Emblica officinalis) on patients with chronic generalized periodontitis, using a single-blind, randomized controlled study design.
- 1.At baseline, all participants fulfilling the I/E criteria would be randomized into Arm I or II.
- 2.All participants in Arm I and II would undergo scaling and root planing (SRP).
- 3.After 1 month, Arm I participants would receive adjunct amla for 2 weeks, and Arm II participants would receive no treatment.
- 4.Both arms would be followed until the end of 6 months and evaluated for clinical and biochemical parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2022
CompletedFirst Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedApril 21, 2026
April 1, 2026
2 years
April 6, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Improvement in clinical parameters (plaque index)
Improvement in plaque index
1, 3 and 6 months
Improvement in clinical parameters (gingival index)
Improvement in gingival index
1,3 and 6 months
Improvement in clinical parameters (bleeding index)
Improvement in bleeding index
1,3 and 6 months
Improvement in clinical parameters (probing pocket depth)
Improvement in probing pocket depth
1,3 and 6 months
Improvement in clinical parameters (clinical attachment level)
Improvement in clinical attachment level
1,3 and 6 months
Secondary Outcomes (4)
Changes in antioxidant levels (Malondialdehyde) in saliva and serum
6 months
Changes in antioxidant levels (glutathione) in saliva and serum
6 months
Changes in anti-inflammatory marker levels (CRP) in serum and saliva
6 months
Changes in anti-inflammatory marker levels (TNF-alpha) in serum and saliva
6 months
Study Arms (2)
Scaling and root planing + Amla
ACTIVE COMPARATORArm I - This group of chronic generalized periodontitis patients would receive the standard of care i.e. scaling and root planing, followed by a full amla berry daily for 2 weeks.
Scaling and root planing
SHAM COMPARATORArm II - This group of chronic generalized periodontitis patients received the standard of care i.e. scaling and root planing
Interventions
Chronic generalized patients were randomly assigned to Arm I and Arm II. Arm I participants underwent scaling and root planing followed by consumption of a whole amla berry.
Chronic generalized patients were randomly assigned to Arm I and Arm II. Arm II participants underwent scaling and root planing only.
Eligibility Criteria
You may qualify if:
- Patients who have at least 20 remaining teeth, with chronic generalized periodontitis, as defined as \> 30 % sites involved (extent) and with moderate to severe involvement (severity) as characterized by \> 2 interproximal sites with clinical attachment loss (CAL) \> 4mm (not on the same tooth) AND/OR \> 5 mm, probing depth (not on the same tooth) AND/OR \> 2 interproximal sites with CAL \> 6 mm AND 1 interproximal site with PD \> 5mm.
- Systemically healthy patients
You may not qualify if:
- Medically compromised patients
- Smokers
- Pregnant and lactating women
- Patients on cholesterol-lowering medication
- Patients who had received any antimicrobial therapy in the past 2 months, on ongoing antimicrobial therapy, or would receive antimicrobials during the course of the study.
- Patients who had undergone any periodontal surgery in the past 6 months
- Patients with a high caries index
- Patients with severe tooth hypersensitivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mahatma Gandhi Postgraduate Institute of Dental Sciences
Puducherry, Puducherry, 605006, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grace T Paul, MDS
Mahatma Gandhi Postgraduate Institute of Dental Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The investigator and outcome assessor were not aware of the arms or the intervention received. The additional intervention (amla dispensing) was conducted by another member, not involved in the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 15, 2026
Study Start
March 20, 2020
Primary Completion
March 15, 2022
Study Completion
September 15, 2022
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Hospital has a SOP for data Sharing. The request should come through a proper channel, only then the individual patient data can be shared.